Alzheimer’S Clinical Neuroscience

Alzheimer's disease, a form of dementia, profoundly impacts clinical neuroscience by challenging our understanding of memory, cognition, and neural degeneration. Clinically, it manifests through progressive memory loss, cognitive decline, and behavioral changes, affecting millions worldwide. Neuroscience research delves into the pathological mechanisms involving beta-amyloid plaques and tau protein tangles, which disrupt neural communication and lead to neuronal death. Imaging techniques like MRI and PET scans aid in diagnosis by revealing brain atrophy and metabolic changes. Treatment focuses on managing symptoms and slowing progression, yet a cure remains elusive. Clinical trials explore new therapies targeting disease mechanisms, offering hope for future breakthroughs. Understanding Alzheimer's through clinical neuroscience is crucial for developing effective interventions and improving the quality of life for those affected by this devastating condition.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua

Jun Hua

Johns Hopkins University , United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Nazneen N Dewji

Nazneen N Dewji

Cenna Biosciences Inc, United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline London

Jacqueline London

Paris Diderot University, France
Tags

Submit your abstract Today

Whatsapp